Skip to main content
Clinical Trials/NCT02260453
NCT02260453
Completed
Phase 3

Randomized Controlled Trial Analyzing the Role of Systematic Preoperative Coronary Angiography Before Elective Carotid Endarterectomy in Patients With Asymptomatic Coronary Artery Disease

University of Roma La Sapienza0 sites426 target enrollmentJanuary 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Carotid Stenosis
Sponsor
University of Roma La Sapienza
Enrollment
426
Primary Endpoint
Non-fatal and fatal myocardial infarction
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the potential benefit of systematic preoperative coronary angiography followed by selective coronary artery revascularization on the incidence of myocardial infarction (MI) in patients without a history of coronary artery disease (CAD) and undergoing carotid endarterectomy (CEA).

Detailed Description

Patients candidates for CEA, with no history of CAD, a normal electrocardiogram (ECG), and a normal cardiac ultrasound were randomized in two groups. In group A (n = 216) all patients underwent coronary angiography before CEA +- coronary artery revascularization. In group B (n = 210) CEA was performed without coronary angiography.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
June 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Roma La Sapienza
Responsible Party
Principal Investigator
Principal Investigator

Giulio Illuminati

Associate Professor of Surgery

University of Roma La Sapienza

Eligibility Criteria

Inclusion Criteria

  • indication for carotid endarterectomy
  • no clinical sign or history of ischemic heart disease
  • no electrical signs of cardiac ischemia
  • left ventricular ejection fraction \>50% at transthoracic echocardiogram.

Exclusion Criteria

  • disabling stroke (mRS ≥3)
  • non atherosclerotic carotid disease
  • severe intracranial carotid artery stenosis
  • contra-indications to heparin, aspirin or clopidogrel.

Outcomes

Primary Outcomes

Non-fatal and fatal myocardial infarction

Time Frame: 30 days through year 3

Secondary Outcomes

  • All-cause and cardiovascular mortality(30 days through year 3)

Similar Trials